Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/Year

September 19, 2016 4:13 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Sarepta Therapeutics (NASDAQ: SRPT) Says Exondys-51 List Price to be $300K/Year

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Momentum Movers

Add Your Comment